The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: A randomized, controlled, double-blinded trial

Annals of Surgery

Volumn 243, Issue 1, 2006, Pages 47-57

  Rizoli, Sandro B ^a   Rhind, Shawn G ^b   Shek, Pang N ^b   Inaba, Kenji ^a   Filips, Dennis ^a   Tein, Homer ^a   Brenneman, Fred ^a   Rotstein, Ori ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CORTICOSTEROID; DEXTRAN 70; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; NORADRENALIN; PLACEBO; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SINGLE DRUG DOSE; TRAUMATIC SHOCK; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, SURFACE; CYTOKINES; DEXTRANS; DOUBLE-BLIND METHOD; FEMALE; HORMONES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; SHOCK, HEMORRHAGIC; WOUNDS, NONPENETRATING;

EID: 30144445372     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000193608.93127.b1     Document Type: Article

References (54)

1. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363:1988-1996.
2. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury. 2003;34:397-404.
3. Maier RV. Pathogenesis of multiple organ dysfunction syndrome: endotoxin, inflammatory cells, and their mediators. Cytokines and reactive oxygen species. Surg Infect (Larchmt). 2000;1:197-205.
4. Rizoli SB, Rotstein OD, Sibbald WJ. The immunological effects of hypertonic saline. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 2002:446-453.
5. Rotstein OD. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma. 2003;54(suppl):203- 206.
6. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling: regulation of the immune response in normal and critically ill states. Crit Care Med. 2000;28:N3-N12.
7. Rhee P, Wang D, Ruff P, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000;28:74-78.
8. Junger WG, Coimbra R, Liu FC, et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock. 1997;8:235-241.
9. Rotstein OD. Novel strategies for immunomodulation after trauma: revisiting hypertonic saline as a resuscitation strategy for hemorrhagic shock. J Trauma. 2000;49:580-583.
10. Kolsen-Petersen JA. Immune effect of hypertonic saline: fact or fiction? Acta Anaesthesiol Scand. 2004;48:667-678.
11. Shukla A, Hashiguchi N, Chen Y, et al. Osmotic regulation of cell function and possible clinical applications. Shock. 2004;21:391-400.
12. Rizoli SB, Kapus A, Fan J, et al. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288-6296.
13. Rizoli SB, Kapus A, Parodo J, et al. Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma. 1999;46:794-798; discussion 798-799.
14. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock. 1998;9:164-170.
15. Rizoli SB, Kapus A, Parodo J, et al. Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression. J Surg Res. 1999;83:130-135.
16. Rizoli SB, Rotstein OD, Parodo J, et al. Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol. 2000;279:C619-C633.
17. Loomis WH, Namiki S, Hoyt DB, et al. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol. 2001;281:C840-C848.
18. Cuschieri J, Gourlay D, Garcia I, et al. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002;168:1389-1396.
19. Gushchin V, Stegalkina S, Alam HB, et al. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma. 2002;52:867-871.
20. Oreopoulos GD, Bradwell S, Lu Z, et al. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages. Surgery. 2001;130:157-165.
21. Oreopoulos GD, Wu H, Szaszi K, et al. Hypertonic preconditioning prevents hepatocellular injury following ischemia/reperfusion in mice: a role for interleukin 10. Hepatology. 2004;40:211-220.
22. Powers KA, Woo J, Khadaroo RG, et al. Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery. 2003;134:312-318.
23. Cross JS, Gruber DP, Gann DS, et al. Hypertonic saline attenuates the hormonal response to injury. Ann Surg. 1989;209:684-691; discussion 691-692.
24. Wade CE, Hannon JP, Bossone CA, et al. Neuroendocrine responses to hypertonic saline/dextran resuscitation following hemorrhage. Circ Shock. 1991;35:37-43.
25. Kramer GC. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma. 2003;54(suppl):89-99.
26. Wade CE, Kramer GC, Grady JJ, et al. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery. 1997;122:609-616.
27. Dubick MA, Wade CE. A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma. 1994;36:323-330.
28. Kreimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine: advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand. 2002;46:625-638.
29. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291:1350-1357.
30. Kolsen-Petersen JA, Nielsen JO, Bendtzen K, et al. Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiol Scand. 2004;48:224-233.
31. Simma B, Burger R, Falk M, et al. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med. 1998;26:1265-1270.
32. Angle N, Hoyt DB, Cabello-Passini R, et al. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma. 1998;45:7-12; discussion 12-13.
33. Ghanekar SA, Maecker HT. Cytokine flow cytometry: multiparametric approach to immune function analysis. Cytotherapy. 2003;5:1-6.
34. Frankenberger M, Sternsdorf T, Pechumer H, et al. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood. 1996;87:373-377.
35. Maddali S, Stapleton PP, Freeman TA, et al. Neuroendocrine responses mediate macrophage function after trauma. Surgery. 2004;136:1038-1046.
36. Angle N, Cabello-Passini R, Hoyt DB, et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock. 2000;14:503-508.
37. Coimbra R, Hoyt DB, Junger WG, et al. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma. 1997;42:602-606; discussion 606-607.
38. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension: the U.S.A. Multicenter Trial. Ann Surg. 1991;213:482-491.
39. Martinez-Mier G, Toledo-Pereyra LH, Ward PA. Adhesion molecules and hemorrhagic shock. J Trauma. 2001;51:408-415.
40. Maekawa K, Futami S, Nishida M, et al. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma. 1998;44:460-468.
41. Rainer TH, Ng MH, Lam NY, et al. Role of monocyte L-selectin in the development of post-traumatic organ failure. Resuscitation. 2001;51:139-149.
42. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71-82.
43. Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol. 2000;67:603-606.
44. +) monocytes by exercise. Am J Physiol Cell Physiol. 2000;279:C578-C586.
45. McCarter MD, Mack VE, Daly JM, et al. Trauma-induced alterations in macrophage function. Surgery. 1998;123:96-101.
46. Kampalath B, Cleveland RP, Chang CC, et al. Monocytes with altered phenotypes in posttrauma patients. Arch Pathol Lab Med. 2003;127:1580-1585.
47. + subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med. 1999;37:209-213.
48. + CD14dim monocytes in a patient with pulmonary alveolar proteinosis. Respirology. 2002;7:273-279.
49. ++ monocytes are a major source of TNF. J Immunol. 2002;168:3536-3542.
50. DeLong WG Jr, Born CT. Cytokines in patients with polytrauma. Clin Orthop 2004:57-65.
51. Ferguson KL, Taheri P, Rodriguez J, et al. Tumor necrosis factor activity increases in the early response to trauma. Acad Emerg Med. 1997;4:1035-1040.
52. Bergmann M, Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr. 2002;114:752-761.
53. Orlic T, Loomis WH, Shreve A, et al. Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and -independent mechanisms. Am J Physiol Cell Physiol. 2002;282:C1261-C1269.
54. Hirsh M, Dyugovskaya L, Bashenko Y, et al. Reduced rate of bacterial translocation and improved variables of natural killer cell and T-cell activity in rats surviving controlled hemorrhagic shock and treated with hypertonic saline. Crit Care Med. 2002;30:861-867.